Posted on
Tuesday, September 1, 2026
For Stephanie Hachey, PhD, receiving an ARCS Foundation Scholar award during the final two years of her doctoral studies at the University of California, Irvine, marked the beginning of a lasting relationship with ARCS.
Today, Hachey is an assistant project scientist at UC Irvine and CEO of ImmunoTarget Therapeutics. She conducts...